S — Class II drug recall D-0447-2024
Completed recall by Specialty Process Labs LLC, reported 2024-04-24, distributed nationwide. Failed Stability Specifications
| Recall number | D-0447-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Specialty Process Labs LLC, Phoenix, AZ, United States |
| Recall initiated | 2024-03-01 |
| Classified | 2024-04-17 |
| Reported by FDA | 2024-04-24 |
| Distributed | Nationwide (US) |
| Quantity | 217 units |
| Reason classes | specification failure |
| NDC | 81305-0100-01, 81305-0100-02, 81305-0100-03 |
| Lot numbers | B10383-1XV, B10453-1X, C10803-1X, E11363-1X, K12753-1X, L13103-1X, L13152-1XV |
| Expiration dates | 2024-11-21, 2025-02-14, 2025-02-15, 2025-03-23, 2025-05-18, 2025-10-12, 2025-11-13 |
Product
S.P Labs, Thyroid, USP, Rx only, For Manufacturing, Processing or Repackaging Use only, Specialty Process Labs, Phoenix, AZ, NDC #'s a) 81305-100-01, b)81305-100-02, c)81305-100-03
Reason for recall
Failed Stability Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0447-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.